TERRY WHITE CHEMISTS RISEDRONATE/Ca 35/1250 risedronate sodium 35 mg tablet and calcium carbonate 1250 mg tablet composite blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

risedronate sodium, Quantity: 35 mg

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

Risedronate sodium

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: lactose; macrogol 8000; colloidal anhydrous silica; titanium dioxide; magnesium stearate; hypromellose; iron oxide red; iron oxide yellow; crospovidone; hyprolose

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

Pack sizes of 7, 14, 28, 84, 112 tablets per pack

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Treatment of osteoporosis.,Treatment of glucocorticoid-induced osteoporosis. ,Preservation of bone mineral density in patients on long term corticosteroid therapy

Sommarju tal-prodott:

Visual Identification: Risedronate tablets are orange round biconvex coated tablets engraved APO on one side RIS above 35 on the other side; Container Type: Multiple containers; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2012-04-13